Clinical Trial Update: Validation of AI-ENDO System in Endoscopic Submucosal Dissection [NA]

View source ↗

Summary

A clinical trial is validating the AI-ENDO System for use during endoscopic submucosal dissection of superficial lesions in the esophagus, stomach, or colon; en…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• AI-ENDO System

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Superficial Esophageal, Gastric or Colorectal Lesions | NA | Status: RECRUITING